Fig. 2 | Scientific Reports

Fig. 2

From: Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies

Fig. 2

Cytopathic effect of WNV infection in the presence of Type II (IFN-γ) and III (IFN-λ1) IFNs. The rate of WNV infection was assessed by measuring virus-induced cytopathic effects (CPE) in ARPE-19 cells (A) and Vero E6 cells (B) at 0, 24, and 48 h post-infection. Cells were pre-treated overnight with type II (IFN-γ) or type III (IFN-λ1) IFNs at concentrations of 10 ng/mL, 1 ng/mL, 100 pg/mL, 50 pg/mL, and 10 pg/mL, followed by infection with 100 TCID50 of WNV. Neither IFN-γ nor IFN-λ1 conferred protection against WNV infection in ARPE-19 or Vero E6 cells at any of the tested concentrations. All experiments were performed in triplicate. The figures have been simplified to display the most relevant time points and virus inoculum. Full data, including additional time points and concentrations, are available in the supplementary materials.

Back to article page